Invest Securities reaffirms its 'buy' opinion on Assystem, with an adjusted price target of €55 to €56, believing that 'more than ever, the stock remains a strong conviction to benefit from the nuclear revival'.

'Quarter after quarter, achievements confirm that the acceleration in nuclear business growth will be faster than initially envisaged', judges the analyst, for whom second-quarter organic growth reflects this dynamic.

Invest Securities also welcomes the slight increase in 2023 targets, as well as the positive message on recruitment and the decline in turnover. The only uncertainty lies in the timing of the disposal of our stakes in Expleo and Framatome," he adds.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.